about
Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistanceThe evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and cloneCommunity-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergenceGlobal distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006Evolution of Staphylococcus aureus by large chromosomal replacements.Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineagesRe-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone.Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France.Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureusA genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic.Estimating recombinational parameters in Streptococcus pneumoniae from multilocus sequence typing data.Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme.Inferring a population structure for Staphylococcus epidermidis from multilocus sequence typing dataPopulation structure of a hybrid clonal group of methicillin-resistant Staphylococcus aureus, ST239-MRSA-III.Clinical and Microbiological Determinants of Outcome in Staphylococcus aureus BacteraemiaSeven novel variants of the staphylococcal chromosomal cassette mec in methicillin-resistant Staphylococcus aureus isolates from Ireland.Genetic background affects stability of mecA in Staphylococcus aureus.Directional gene movement from human-pathogenic to commensal-like streptococciMoraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.Predicting high prevalence of community methicillin-resistant Staphylococcus aureus strains in nursing homesPredictors of hospitals with endemic community-associated methicillin-resistant Staphylococcus aureus.Influence of recombination and niche separation on the population genetic structure of the pathogen Streptococcus pyogenesHigh interlaboratory reproducibility of DNA sequence-based typing of bacteria in a multicenter studyRecombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequencesCombined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus biofilm formation.Diversity of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from inpatients of 30 hospitals in Orange County, CaliforniaA population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005.Determining the genetic structure of the natural population of Staphylococcus aureus: a comparison of multilocus sequence typing with pulsed-field gel electrophoresis, randomly amplified polymorphic DNA analysis, and phage typingHow clonal is Staphylococcus aureus?Multilocus sequence typing of Staphylococcus aureus with DNA array technologyThe evolution of a resistant pathogen--the case of MRSA.Multilocus sequence typing and the evolution of methicillin-resistant Staphylococcus aureus.Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia.Analyses of clonality and the evolution of bacterial pathogens.Differences in methicillin-resistant Staphylococcus aureus strains isolated from pediatric and adult patients from hospitals in a large county in California.Phylogenetic Distribution of CRISPR-Cas Systems in Antibiotic-Resistant Pseudomonas aeruginosa.Evaluation of molecular typing methods in characterizing a European collection of epidemic methicillin-resistant Staphylococcus aureus strains: the HARMONY collection.The role of regulated clinical trials in the development of bacteriophage therapeutics.A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions
P50
Q22066348-243475CD-EA4F-441C-A1C1-708D871B47E7Q24530652-F160BBA2-6A63-4CCA-BE5F-7018197D6FC0Q24548700-C24EABB9-B862-4C03-A559-85BCEB256DAFQ24598936-428712CF-858C-49EA-B246-2066D81A1568Q24652423-9AD9D9DE-8355-4D5E-83EA-FA74A6F9DECCQ30336393-3143E057-DD1C-4FB2-9F30-DB43C9A3B437Q30341876-D1DD2045-52B3-40BF-A437-80F3090A5586Q30350486-803785F6-A11F-42B0-A68B-6646F922EA3CQ30353240-7989062A-1BC2-42F7-B606-C8ABCF00C1D2Q30416768-F79A0C22-E551-4EE9-90D7-D5319631C1F3Q30425667-C57406F9-9C48-4FF8-8002-D10A8639244CQ30588690-D9D1AC7F-318C-422C-AA09-2D2964C0C4B2Q30883088-A2743BE6-85A9-4FDD-B6D6-A76D034275E8Q33269053-27BD7CCC-CDDF-4138-92F9-74570DF0302AQ33523016-1D858764-FEAE-475B-97B6-2034A6A9CA16Q33734119-5ECFEF56-1B2E-4E6B-809F-19F7805A4579Q33770114-B545D342-A858-4599-84D3-D01001B8D3DFQ33859019-AB91318E-23D6-4370-A984-E76E53C41C2FQ34008545-4C333B99-FBA3-4B2E-9405-58D3AFA1A77DQ34064654-FEA367AE-E663-45EB-ADD5-7B1F99508CDFQ34117713-9D3F69DA-1578-4DAC-8734-D1C689DB430DQ34118208-521D588A-B3D8-446C-A090-94B7CE96E585Q34120910-B5DF9209-9C11-40DB-9A1F-6B534115B370Q34430650-BDE16BEB-2F87-4168-9885-F1105FE7EAA4Q34588929-AF74B7CB-09F8-44E1-877C-DAF7980D5B1CQ34594381-880A30BB-9159-48C3-B89E-9608D627F780Q34700948-A66431B9-6B87-443D-8533-E2C0A772BA8DQ34773796-90D25D22-E491-49B8-9573-0F41AEBFCEA3Q34988995-0FD6FDD0-6081-46CC-A409-7BFF84420880Q35006020-FCB3CEAE-B41B-4A7A-874F-5B8C294C0C91Q35155577-38333919-A03A-4980-822D-8A9E5FE2A8D8Q35559657-A81CF245-679E-4E50-96D6-0664F43D4154Q35647350-22948566-41CB-4465-994A-4768E90DB3B0Q35714895-13D588AF-6F42-453B-803C-1048662ED14CQ35804703-2456A17C-5E76-4D92-8C76-7137679E92C2Q35807224-78D2FDEC-0184-4696-A59A-CC4144DCD932Q35851888-021CBCFB-4B78-428B-952B-D50C75267C6BQ35913887-41E073C4-210F-42A6-9A06-55B17C494B72Q36135134-97DBD13F-0A8F-4AD5-93B0-7AAA13E9BFF4Q36483482-BB2C1039-94AD-4C30-80A6-0E9A8122FACF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mark Enright
@ast
Mark Enright
@en
Mark Enright
@es
Mark Enright
@nl
Mark Enright
@sl
type
label
Mark Enright
@ast
Mark Enright
@en
Mark Enright
@es
Mark Enright
@nl
Mark Enright
@sl
prefLabel
Mark Enright
@ast
Mark Enright
@en
Mark Enright
@es
Mark Enright
@nl
Mark Enright
@sl
P106
P21
P31
P496
0000-0001-5273-8750